Stockreport

Traws Pharma Completes Enrollment of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients; Announces Plans for Added Indication for Tivoxavir Marboxil as a Pro...

Traws Pharma, Inc.  (TRAW) 
PDF and faster time to sustained symptom resolution; results recapitulated in PAXLOVID ® -ineligible patients, representing a significant population with few effective treat [Read more]